What oral powder medication is recommended for treating an uncomplicated urinary tract infection in an otherwise healthy adult?

Fosfomycin: The Oral Powder for Uncomplicated UTI

For an otherwise healthy adult with uncomplicated urinary tract infection, fosfomycin tromethamine 3 grams as a single oral powder dose is the recommended treatment.

Standard Dosing & Administration

• Mix one 3-gram sachet of fosfomycin powder with 90–120 mL of water and take as a single oral dose, with or without food. 1
• The powder maintains therapeutic urinary concentrations for 24–48 hours after a single dose, which is sufficient to eradicate most uropathogens causing uncomplicated cystitis. 2
• Do not take the powder in dry form—always dissolve it in water before ingesting. 1
• This is a one-time dose; do not repeat the medication. 2

Clinical Efficacy

• Fosfomycin achieves approximately 91% clinical cure rates in women with uncomplicated cystitis, with bacteriological eradication rates of 75–90% when assessed 5–11 days after therapy. 2, 3
• The single-dose regimen provides comparable efficacy to 3–7 day courses of ciprofloxacin, nitrofurantoin, or trimethoprim-sulfamethoxazole for uncomplicated lower UTIs. 4
• The American Urological Association, European Association of Urology, and American College of Physicians all recommend fosfomycin as a first-line option (Grade A/B evidence) for uncomplicated cystitis in women. 2

When to Use Fosfomycin

• Fosfomycin is particularly appropriate when local trimethoprim-sulfamethoxazole resistance exceeds 20%, as it maintains excellent activity against multidrug-resistant organisms including ESBL-producing E. coli. 2
• It is safe in pregnancy and recommended for both asymptomatic bacteriuria and symptomatic cystitis in pregnant women. 2
• The single-dose convenience improves adherence compared to 3–7 day regimens while causing minimal disruption to intestinal flora. 2

Critical Contraindications

• Never use fosfomycin for pyelonephritis or suspected upper urinary tract infections—it does not achieve adequate renal tissue concentrations. 2
• Do not use in men with UTIs, as clinical efficacy data are limited in this population. 2
• Avoid in patients with fever >38°C, flank pain, or costovertebral angle tenderness, which suggest upper tract involvement requiring different therapy. 2

When Treatment Fails

• If symptoms persist after 2–3 days or recur within 2 weeks, obtain a urine culture and switch to a different antibiotic class for a full 7-day course. 2
• Consider nitrofurantoin 100 mg twice daily for 5 days or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if local resistance <20%) as alternative agents. 2
• Reserve fluoroquinolones only for culture-proven resistant pathogens. 2

Common Pitfalls to Avoid

• Do not use fosfomycin for "borderline" upper tract symptoms—any flank pain, fever, or systemic signs requires a fluoroquinolone or parenteral cephalosporin instead. 2
• Routine urine cultures are unnecessary for typical uncomplicated cystitis; obtain cultures only if symptoms persist, recur within 2 weeks, or if the patient is pregnant. 2
• Do not treat asymptomatic bacteriuria except in pregnant women or before urological procedures that breach the mucosa. 2

Safety Profile

• The most common adverse effects are diarrhea, nausea, and headache, occurring in 5.6–28% of patients. 2
• Fosfomycin has minimal propensity for collateral damage to intestinal flora compared to fluoroquinolones and cephalosporins. 2
• Resistance rates remain remarkably low at only 2.6% for initial E. coli infections and 5.7% at 9 months. 2